Literature DB >> 15983229

Hepatic lipase gene variant -514C>T is associated with lipoprotein and insulin sensitivity response to regular exercise: the HERITAGE Family Study.

Margarita Teran-Garcia1, Nicola Santoro, Tuomo Rankinen, Jean Bergeron, Treva Rice, Arthur S Leon, D C Rao, James S Skinner, Richard N Bergman, Jean-Pierre Després, Claude Bouchard.   

Abstract

We investigated the associations between the hepatic lipase gene (LIPC) -514C>T polymorphism and lipases, lipoproteins, and insulin sensitivity (Si) responses to exercise training. Hepatic lipase and lipoprotein lipase activities, plasma lipoprotein levels, and Si were measured in the sedentary state and post-exercise training in the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) Family Study (n=662). The LIPC -514C allele frequency was 0.516 (blacks) and 0.796 (whites). Baseline and post-exercise training hepatic lipase activities were 40% higher in CC homozygotes (P < 0.0001) in both races. Black CC homozygotes had lower baseline lipoprotein lipase activity, HDL cholesterol, HDL3, and apolipoprotein (apo)A-1 concentrations. White CC homozygotes had lower baseline HDL cholesterol, apoA-1, LDL cholesterol, and apoB levels that remained low post-exercise training. Baseline Si was not associated with the LIPC genotypes. However, training-induced improvements in Si both in blacks and whites were greater in CC homozygotes (+1.25 +/- 0.2 and +0.22 +/- 0.2 microU.min(-1).ml(-1)) than in the TT genotype (+0.27 +/- 0.3 and -0.97 +/- 0.3 microU.min(-1).ml(-1)) (P = 0.008 and P = 0.002, respectively). The LIPC -514C allele was associated with higher hepatic lipase activity in sedentary and physically active states and better Si responses to regular exercise both in black and white individuals. The benefits from an exercise program on Si are likely to be substantial in the general population given the high frequency of the LIPC -514C allele, particularly in whites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15983229     DOI: 10.2337/diabetes.54.7.2251

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

Review 1.  The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype.

Authors:  John D Brunzell; Alberto Zambon; Samir S Deeb
Journal:  Biochim Biophys Acta       Date:  2011-09-25

2.  Genetic variation in the hepatic lipase gene and the risk of coronary heart disease among US diabetic men: potential interaction with obesity.

Authors:  C Zhang; R Lopez-Ridaura; E B Rimm; T Li; D J Hunter; F B Hu
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

3.  Hepatic lipase gene -514C>T variant is associated with exercise training-induced changes in VLDL and HDL by lipoprotein lipase.

Authors:  Tina E Brinkley; Amy Halverstadt; Dana A Phares; Robert E Ferrell; Ronald L Prigeon; James M Hagberg; Andrew P Goldberg
Journal:  J Appl Physiol (1985)       Date:  2011-09-29

4.  Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C levels and the risk of myocardial infarction in women of European ancestry.

Authors:  Tariq Ahmad; Daniel I Chasman; Julie E Buring; I-Min Lee; Paul M Ridker; Brendan M Everett
Journal:  Circ Cardiovasc Genet       Date:  2011-01-20

5.  Dietary fat modulation of hepatic lipase variant -514 C/T for lipids: a crossover randomized dietary intervention trial in Caribbean Hispanics.

Authors:  C E Smith; M I Van Rompay; J Mattei; J F Garcia; B Garcia-Bailo; A H Lichtenstein; K L Tucker; J M Ordovás
Journal:  Physiol Genomics       Date:  2017-09-22       Impact factor: 3.107

6.  Physical inactivity interacts with an endothelial lipase polymorphism to modulate high density lipoprotein cholesterol in the GOLDN study.

Authors:  Caren E Smith; Donna K Arnett; Michael Y Tsai; Chao-Qiang Lai; Laurence D Parnell; Jian Shen; Martin Laclaustra; Mireia Junyent; José M Ordovás
Journal:  Atherosclerosis       Date:  2009-03-25       Impact factor: 5.162

7.  LIPC variants in the promoter and intron 1 modify HDL-C levels in a sex-specific fashion.

Authors:  Mary F Feitosa; Richard H Myers; James S Pankow; Michael A Province; Ingrid B Borecki
Journal:  Atherosclerosis       Date:  2008-09-17       Impact factor: 5.162

8.  LDL triglycerides, hepatic lipase activity, and coronary artery disease: An epidemiologic and Mendelian randomization study.

Authors:  Günther Silbernagel; Hubert Scharnagl; Marcus E Kleber; Graciela Delgado; Tatjana Stojakovic; Reijo Laaksonen; Jeanette Erdmann; Tuomo Rankinen; Claude Bouchard; Ulf Landmesser; Heribert Schunkert; Winfried März; Tanja B Grammer
Journal:  Atherosclerosis       Date:  2018-12-28       Impact factor: 5.162

9.  Improvements in glucose homeostasis in response to regular exercise are influenced by the PPARG Pro12Ala variant: results from the HERITAGE Family Study.

Authors:  S-M Ruchat; T Rankinen; S J Weisnagel; T Rice; D C Rao; R N Bergman; C Bouchard; L Pérusse
Journal:  Diabetologia       Date:  2009-12-31       Impact factor: 10.122

10.  VLDL hydrolysis by hepatic lipase regulates PPARδ transcriptional responses.

Authors:  Jonathan D Brown; Eric Oligino; Daniel J Rader; Alan Saghatelian; Jorge Plutzky
Journal:  PLoS One       Date:  2011-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.